Interact to see
Advertisement
Advertisement
HGHRX vs VHCIX
HGHRX vs VHCIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
HGHRX vs. VHCIX commentary
Feb 04, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHRX is a StrongBuy and VHCIX is a Buy.
FUNDAMENTALS
Fundamentals
VHCIX has more cash in the bank: 19.9B vs. HGHRX (841M). VHCIX pays higher dividends than HGHRX: VHCIX (1.62) vs HGHRX (0.00). HGHRX was incepted earlier than VHCIX: HGHRX (19 years) vs VHCIX (22 years). HGHRX (1.63) is less costly to investors than VHCIX (0.09). HGHRX is a more actively managed with annual turnover of: 49.00 vs. VHCIX (4.00). HGHRX has a lower initial minimum investment than VHCIX: HGHRX (0) vs VHCIX (100000). VHCIX annual gain was more profitable for investors over the last year : 5.96 vs. HGHRX (4.56). VHCIX return over 5 years is better than : 24.08 vs. HGHRX (-9.67).
| HGHRX | VHCIX | HGHRX / VHCIX | |
| Total Expense Ratio | 1.63 | 0.09 | 1,811% |
| Annual Report Gross Expense Ratio | 1.63 | 0.09 | 1,811% |
| Fund Existence | 19 years | 22 years | - |
| Gain YTD | -0.431 | -0.459 | 94% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 100000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 841M | 19.9B | 4% |
| Annual Yield % from dividends | 0.00 | 1.62 | - |
| Returns for 1 year | 4.56 | 5.96 | 76% |
| Returns for 3 years | 9.82 | 17.05 | 58% |
| Returns for 5 years | -9.67 | 24.08 | -40% |
| Returns for 10 years | 29.84 | 146.61 | 20% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement